Sign in >>

News item: DUSA Pharmaceuticals Completes Enrollment in Phase 2 Studies of Levulan(R) Kerastick(R) Photodynamic Therapy

WILMINGTON, Mass. — DUSA Pharmaceuticals, Inc.® , a dermatology company that is developing and marketing its Levulan® Photodynamic Therapy (PDT) platform, announced today that patient enrollment is …

Posted about 1 year ago

Continue reading...

Back to news index



Send feedback about this page
Email a link to this page

This topic elsewhere

Loading...
Loading...